The Effectiveness of Tecar Therapy in Management of Calf Muscle Strain Injuries (MS)
25. April 2026 aktualisiert von: Nabil Mahmoud Ismail Abdel-Aal, Cairo University
this study will be conducted to investigate the effect of TECAR Therapy on quality of landing, healing and Function in patient with Calf Muscle Strain.
Studienübersicht
Status
Noch keine Rekrutierung
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Calf muscle strain is one of the most common muscle injuries in high-performance athletes and contributes to substantial player downtime because of its high mean time to return to sport and occurrence during critical periods in the competitive season.
Published reports on lower-body muscle strain have provided frequent updates on the rehabilitation of high-profile muscle groups, such as the hamstring muscles, and improvements to calf strain management are seldom discussed despite the prevalence of these injuries in competitive sports.
In this article, we discuss the diagnosis, treatment, outcomes, risk factors, and prevention of calf muscle strain in athletes.Transfer of Electricity-Capacitive and Resistive (Tecar) therapy is considered a special form of energy that uses frequencies between 300 KHz and 1 MHz and is characterized as a non-invasive high-frequency energy that awakens the body's natural ability to self-regenerate.
Thus, it promotes the natural physiological processes of the tissue metabolically, transferring energy without introducing radiation from the external environment.
TECAR therapy stands out as a promising yet underexplored modality.
Its mechanism of action-utilizing both capacitive and resistive energy transfer-suggests a novel approach to addressing musculoskeletal injuries and pain.
While preliminary studies and clinical applications hint at its potential advantages, such as improved tissue healing and pain relief, a comprehensive evaluation of the existing research is necessary to fully understand the role of TECAR therapy in rehabilitation
Studientyp
Interventionell
Einschreibung (Geschätzt)
60
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Nabil Abdel-Aal, professor
- Telefonnummer: 01200133613
- E-Mail: nabil.mahmoud@cu.edu.eg
Studieren Sie die Kontaktsicherung
- Name: Hossam Mostafa, master
- Telefonnummer: 01092727746
- E-Mail: h.elshatory@gmail.com
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
Akzeptiert gesunde Freiwillige
Nein
Beschreibung
Inclusion Criteria:
- Aged between 16-39 years of age.
- not having suffered leg injuries in the past 6 months.
- not having suffered a triceps sural rupture in the past two years.
- be diagnosed with latent MTPs in the gastric-soleus complex through manual therapy in the dominant side.
- Presence of Calf muscles Strain evaluated by Ultrasonography.
- Athlete willing and able to participate in an exercise program safely.
- The radiologist also assessed whether the tendon ends could be reduced in passive plantar flexion of the ankle joint with the knee extended.
- Athlete BMI from 18.5 to 24.9 kg / m2
Exclusion Criteria:
- connective tissue pathology.
- lymphatic disorders (lymphadenopathy).
- Skin injuries (open wounds, infection, psoriasis, tattoos, hematoma).
- peripheral neuropathies.
- previous fractures.
- previous lower limb surgeries (in the past 12 months).
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: TECAR therapy
Thirty patients will receive TECAR therapy combined with conventional treatment three times per week for 12 weeks.
|
The TECAR intervention was administered to the calf muscle using the Zimmer devicein capacitive (CAP) mode for a duration of 20 min.
The therapy was applied with the signal at a variable power with a maximum of 300 W. The frequency used was 500 kHz with an intensity of 40%.
The intervention was standardized to a distal-to-proximal stroking rhythm with moderate pressure.
For the TECAR intervention, the capacitive (CAP) mode at 500 kHz with 40% intensity and a maximum power of 300 W was chosen to optimize deep tissue heating and promote local blood flow and tissue recovery.
The 20 min duration reflects protocols commonly used in therapeutic settings for muscle recovery and rehabilitation plus conventional therapy
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.
|
|
Aktiver Komparator: conventional treatment
Thirty patients will receive conventional treatment three times per week for 12 weeks.
|
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
size of injury
Zeitfenster: up to 12 weeks
|
ultrasonography device will be used to assess size of injury
|
up to 12 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
landing error score system
Zeitfenster: up to 12 weeks
|
Landing Error Scoring System is a clinical tool used to assess jump-landing mechanics for the video from my jumb land aplication .
the feet, ankle, knees, hip, trunk, shoulder, neck and head posture is assessed through the video.
it is a 17-item .
According to the performance sheet, the questions 1-15 are Yes/No questions that are rated as 0 or 1.
The questions 16 are rated as 0, 1, and 2; 0 = soft, 1= average and 2= stiff.
the question 17 are rated as 0,1,2; 0= excellent,1 average and 2= poor, so the total score ranges from zero to 19.
A higher score indicates poor technique in landing from a jump; a lower score indicates better jump-landing technique.
the score are categorized as excellent which less than 4, good score more than four and less than or equal 5, moderate score less than four and poor more than six
|
up to 12 weeks
|
|
jump height
Zeitfenster: up to 12 weeks
|
The vertical jump test was performed as a one-legged counter movement jump (CMJ).
Starting position was in an upright position with the hands placed behind the back.
The subjects quickly bent the knee as much as desired and then immediately jumped upward attempting to maximize the height jumped.
The subjects performed three maximal approved trials for each leg, starting with the right and alternating between the right and the left leg.
However, if the subject increased hop performance in all three jumps, additional jumps were performed until no increase was seen.
The best jump height for each leg was used for data analysis.
|
up to 12 weeks
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Geschätzt)
1. Mai 2026
Primärer Abschluss (Geschätzt)
1. Dezember 2026
Studienabschluss (Geschätzt)
1. Dezember 2026
Studienanmeldedaten
Zuerst eingereicht
25. April 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
25. April 2026
Zuerst gepostet (Tatsächlich)
1. Mai 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
1. Mai 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
25. April 2026
Zuletzt verifiziert
1. April 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- P.T.REC/012/006406
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .